Literature DB >> 24966903

Leptin deficiency recapitulates the histological features of pulmonary arterial hypertension in mice.

Metin Aytekin1, Adriano R Tonelli2, Carol F Farver3, Ariel E Feldstein4, Raed A Dweik5.   

Abstract

UNLABELLED: Leptin is a neuroendocrine peptide released by adipose tissue that enhances metabolism and acts on the hypothalamus to suppress appetite. Leptin also regulates aspects of cardiovascular function and low serum leptin has been associated with increased mortality in humans. We hypothesized that leptin deficiency alters the structure and function of the pulmonary vasculature.
METHODS: We examined two groups of C57BL/6 male mice aged 12 weeks: five ob/ob (B6.VLepob/ob) leptin-deficient and five wild type (WT) (C57BL/6) control mice. As expected, weight was significantly greater in ob/ob mice relative to WT mice [weight (g), Mean±SD): ob/ob 52±2.5 g, wild type 30±2.5 g; p<0.001]. The pulmonary vasculature of ob/ob mice and WT control animals was examined by histology, immunohistochemistry and immunofluorescence staining.
RESULTS: Pulmonary arterial wall thickness was significantly increased in ob/ob mice relative to WT littermates [median (interquartile range) distance in pixels: ob/ob 0.13 (0.05-0.18), wild type 0.03 (0.02-0.04); p=0.001]. The ob/ob mice also exhibited significant right ventricular hypertrophy in comparison to control animals [RV thickness (Mean±SD): ob/ob 0.75±0.19, wild type; 0.58±0.13 p<0.001]. We observed substantial macrophage infiltration and abundant proliferation of myofibroblasts and fibroblasts in histological sections of pulmonary arterioles of ob/ob mice. In addition, we noted increased hyaluronan deposition, colocalizing with SMC-actin in the pulmonary vasculature of ob/ob mice relative to WT controls.
CONCLUSIONS: The pulmonary pathology of leptin deficiency in ob/ob mice recapitulates many of the histological features of pulmonary vascular diseases, including pulmonary hypertension, suggesting that leptin deficiency is associated to the pathogenesis of pulmonary vascular disease.

Entities:  

Keywords:  Leptin; obesity; pulmonary hypertension; vasculature

Mesh:

Substances:

Year:  2014        PMID: 24966903      PMCID: PMC4069962     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  53 in total

Review 1.  The role of nitric oxide in cardiovascular diseases.

Authors:  Khalid M Naseem
Journal:  Mol Aspects Med       Date:  2005-01-24

2.  Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin.

Authors:  Ling Li; Jean-Claude Mamputu; Nicolas Wiernsperger; Geneviève Renier
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

3.  New predictors of outcome in idiopathic pulmonary arterial hypertension.

Authors:  Steven M Kawut; Evelyn M Horn; Ketevan K Berekashvili; Robert P Garofano; Rochelle L Goldsmith; Allison C Widlitz; Erika B Rosenzweig; Diane Kerstein; Robyn J Barst
Journal:  Am J Cardiol       Date:  2005-01-15       Impact factor: 2.778

4.  Mechanisms mediating renal sympathetic activation to leptin in obesity.

Authors:  Donald A Morgan; Daniel R Thedens; Robert Weiss; Kamal Rahmouni
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-24       Impact factor: 3.619

5.  Low serum leptin predicts mortality in patients with chronic kidney disease stage 5.

Authors:  Alexandra Scholze; Dirk Rattensperger; Walter Zidek; Martin Tepel
Journal:  Obesity (Silver Spring)       Date:  2007-06       Impact factor: 5.002

6.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

7.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

8.  High levels of hyaluronan in idiopathic pulmonary arterial hypertension.

Authors:  Metin Aytekin; Suzy A A Comhair; Carol de la Motte; Sudip K Bandyopadhyay; Carol F Farver; Vincent C Hascall; Serpil C Erzurum; Raed A Dweik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-09-05       Impact factor: 5.464

9.  Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

Authors:  D J Stewart; R D Levy; P Cernacek; D Langleben
Journal:  Ann Intern Med       Date:  1991-03-15       Impact factor: 25.391

10.  Leptin, the product of Ob gene, promotes angiogenesis.

Authors:  A Bouloumié; H C Drexler; M Lafontan; R Busse
Journal:  Circ Res       Date:  1998-11-16       Impact factor: 17.367

View more
  8 in total

1.  Is pulmonary hypertension a metabolic disease?

Authors:  Jarrod Barnes; Raed A Dweik
Journal:  Am J Respir Crit Care Med       Date:  2014-11-01       Impact factor: 21.405

Review 2.  Vascular Metabolic Mechanisms of Pulmonary Hypertension.

Authors:  Xiao-Fan Shi; Yun-Chao Su
Journal:  Curr Med Sci       Date:  2020-07-17

Review 3.  Pulmonary vascular dysfunction in metabolic syndrome.

Authors:  Conor Willson; Makiko Watanabe; Atsumi Tsuji-Hosokawa; Ayako Makino
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

Review 4.  Insights into the pulmonary vascular complications of heart failure with preserved ejection fraction.

Authors:  Yen-Chun Lai; Longfei Wang; Mark T Gladwin
Journal:  J Physiol       Date:  2018-12-30       Impact factor: 5.182

5.  Do single or sequential measurements of leptin and adiponectin in plasma have prognostic value in pulmonary arterial hypertension?

Authors:  Adriano R Tonelli; Wassim H Fares; Wael Dakkak; Youlan Rao; Xuan Zhou; Raed A Dweik
Journal:  Pulm Circ       Date:  2017-06-27       Impact factor: 3.017

6.  Obesity alters oestrogen metabolism and contributes to pulmonary arterial hypertension.

Authors:  Kirsty M Mair; Katie Y Harvey; Alasdair D Henry; Dianne Z Hillyard; Margaret Nilsen; Margaret R MacLean
Journal:  Eur Respir J       Date:  2019-06-13       Impact factor: 16.671

Review 7.  The Glycobiology of Pulmonary Arterial Hypertension.

Authors:  Shia Vang; Phillip Cochran; Julio Sebastian Domingo; Stefanie Krick; Jarrod Wesley Barnes
Journal:  Metabolites       Date:  2022-04-01

Review 8.  Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension.

Authors:  Kirsty M Mair; Rosemary Gaw; Margaret R MacLean
Journal:  Pulm Circ       Date:  2020-09-18       Impact factor: 3.017

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.